To verify the role of tumor cell-derived IL-33 in T cell responses, we constructed IL-33-overexpressing CRC cell lines (Figure S5B-C) and co-cultured these cells with T cells from PBMCs (Figure 2H). This evidence concerns the gene IL33 and colorectal carcinoma.